Botulinum toxin injection for facial wrinkles
- PMID: 25077722
Botulinum toxin injection for facial wrinkles
Abstract
Botulinum toxin injection for treatment of facial wrinkles is the most frequently performed cosmetic procedure in the United States, and it is one of the most common entry procedures for clinicians seeking to incorporate aesthetic treatments into their practice. Treatment of frown lines and crow's feet, which are the cosmetic indications approved by the U.S. Food and Drug Administration, and horizontal forehead lines, offers predictable results, has few adverse effects, and is associated with high patient satisfaction. Wrinkles are formed by dermal atrophy and repetitive contraction of underlying facial musculature. Botulinum toxin is a potent neurotoxin that inhibits release of acetylcholine at the neuromuscular junction. Injection of small quantities of botulinum toxin into specific overactive muscles causes localized muscle relaxation that smooths the overlying skin and reduces wrinkles. Botulinum toxin effects take about two weeks to fully develop and last three to four months. Dynamic wrinkles, seen during muscle contraction, yield more dramatic results than static wrinkles, which are visible at rest. Botulinum toxin injection is contraindicated in persons with keloidal scarring, neuromuscular disorders (e.g., myasthenia gravis), allergies to constituents of botulinum toxin products, and body dysmorphic disorder. Minor bruising can occur with botulinum toxin injection. Temporary blepharoptosis and eyebrow ptosis are rare complications that are technique-dependent; incidence declines as injector skill improves.
Comment in
-
Cosmetic procedures in family medicine.Am Fam Physician. 2014 Aug 1;90(3):136-7. Am Fam Physician. 2014. PMID: 25077717 No abstract available.
Summary for patients in
-
Information from your family doctor. Cosmetic botulinum toxin injection.Am Fam Physician. 2014 Aug 1;90(3):Online. Am Fam Physician. 2014. PMID: 25077726 No abstract available.
Similar articles
-
Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.Am J Clin Dermatol. 2011 Dec 1;12(6):377-88. doi: 10.2165/11592100-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21877763 Review.
-
Cosmetic indications for botulinum A toxin.Semin Ophthalmol. 1998 Sep;13(3):142-8. doi: 10.3109/08820539809066090. Semin Ophthalmol. 1998. PMID: 9787215 Review.
-
Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.J Cosmet Dermatol. 2007 Sep;6(3):152-8. doi: 10.1111/j.1473-2165.2007.00325.x. J Cosmet Dermatol. 2007. PMID: 17760691
-
Multipoint and multilevel injection technique of botulinum toxin A in facial aesthetics.J Cosmet Dermatol. 2014 Jun;13(2):135-42. doi: 10.1111/jocd.12090. J Cosmet Dermatol. 2014. PMID: 24910277
-
[Botulinum toxin A in the treatment of wrinkles in the upper third of the face].Ann Dermatol Venereol. 2009 Oct;136 Suppl 6:S299-305. doi: 10.1016/S0151-9638(09)72537-2. Ann Dermatol Venereol. 2009. PMID: 19931689 French.
Cited by
-
Wrinkle-Improving Effect of Novel Peptide That Binds to Nicotinic Acetylcholine Receptor.Int J Mol Sci. 2024 Jul 18;25(14):7860. doi: 10.3390/ijms25147860. Int J Mol Sci. 2024. PMID: 39063099 Free PMC article.
-
Pharmacotherapy for Keloids and Hypertrophic Scars.Int J Mol Sci. 2024 Apr 25;25(9):4674. doi: 10.3390/ijms25094674. Int J Mol Sci. 2024. PMID: 38731893 Free PMC article. Review.
-
Botox Optimization Algorithm: A New Human-Based Metaheuristic Algorithm for Solving Optimization Problems.Biomimetics (Basel). 2024 Feb 23;9(3):137. doi: 10.3390/biomimetics9030137. Biomimetics (Basel). 2024. PMID: 38534822 Free PMC article.
-
The efficacy and safety of neubotulinumtoxinA for the treatment of forehead horizontal lines in Asians - A clinical, prospective, interventional, split-face study.Skin Res Technol. 2024 Apr;30(4):e13644. doi: 10.1111/srt.13644. Skin Res Technol. 2024. PMID: 38533764 Free PMC article.
-
The Patient Journey in Facial Aesthetics: Findings from a European Consensus Meeting on Improving the Quality of Life for Patients Receiving Botulinum Toxin Injections.Clin Cosmet Investig Dermatol. 2024 Feb 2;17:329-337. doi: 10.2147/CCID.S446891. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 38327550 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical